Loading…
Based on limited metadata, the FDA issued a Warning Letter to Oglesby & Butler on March 29, 2018, regarding a product classified as "Other" (specific product type not identified in available metadata). Without access to the full warning letter text or subject line details, the specific nature of the violations cannot be determined from this metadata alone. The issuing office information is also unavailable, which limits clarity on the exact regulatory pathway and compliance requirements involved. This summary should be supplemented with the full letter text to understand the complete scope of violations and required corrective actions.